The collegiate board of Anvisa (National Health Surveillance Agency) approved, this Monday (21), the sale of the drug Paxlovid to pharmacies and private hospitals in the country. Produced by Pfizer, the drug to treat Covid-19 is already incorporated into the SUS (Single Health System).
The decision authorizes the supply of the drug to the pharmacy and its sale can only be carried out with a medical prescription.
Paxlovid had its emergency use approved in Brazil in March of this year. It is indicated for adults who are not using oxygenation, but who are at risk of developing into severe cases of Covid-19.
The medicine is composed of two antivirals: nirmatrelvir and ritonavir. It acts to reduce the activity of the 3LC enzyme, associated with viral replication of Sars-CoV-2. The result is control of virus replication in human cells.
According to Anvisa, the measure considered the current epidemiological scenario, with the circulation of new subvariants of omicron and the increase in cases of the disease in the country.
“The medicine must be dispensed exclusively by the pharmacist, and the user must be instructed that the medicine is for individual and exclusive use to the patient who underwent medical evaluation and who received the prescription”, said the agency, in a note.
your subscription can be worth even more
Do you already know the advantages of being a Folha subscriber? In addition to having access to reports and columns, you have exclusive newsletters (find out here). You can also download our free app from the Apple Store or Google Play to receive alerts for the top news of the day. Your subscription helps us to create independent and quality journalism. Thanks!
your signature is worth a lot
More than 180 reports and analyzes published each day. A team with more than 200 columnists and bloggers. A professional journalism that supervises the public power, conveys useful and inspiring news, counterpoints the intolerance of social networks and draws a clear line between truth and lies. How much does it cost to help produce this content?
SUBSCRIBE FOR BRL 1.90 IN THE 1st MONTH
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.